Contract Award Notice |
|
| TRR | 29620175 |
| Organization | Ministerio de Defensa Nacional | Dirección Nacional de Sanidad de las Fuerzas Armadas |
| Tender No | Licitación Abreviada 749/2025 |
| Funded By | Self-Funded |
| Country | Uruguay , South America |
| Contract Value | 262,666 |
Work Detail |
|
Contract Award For Sedants, Neuroleptics, Anti-Infectives And Ophthalmics Item No2 Carbamazepine Suspension Cód. Article 31412 , Item No3 Cyclosporine A Injectable Cod. Article 31320 , Item No4 Antibiotics And Associated Corticoids Ophthalmic Use Cod. Article 26092 , Item No7 Lidocaine Spray Cod. Article 26269 , Item No. Midazolam Injectable Cod. Article 26296 , Item No9 Injectable Milrinone Cod. Article 37614 , Item No10 Injectable Moxifloxacin Code. Article 69184 , Item No11 N-Acetyl Cystine Powder Cod. Article 75697 , Item No12 Injectable Naloxone Code. Article 26305 , Item No13 Injectable Nitroglycerine Cod. Article 31431 , Item No14 Oseltamivir Tables Cod. Article 62133 , Item No16 Injectable Tenecteplase Cod. Article 69882 , Item No17 Terbinaphine Dermic Use Cod. Item 69439 , Item No20 Brimonidine Ophthalmic Solution Cod. Article 28324 , Item No. 21 Cyclopentolate Cod. Article 26065 , Item No22 Ciprofloxacin Colyrio Cod. Article 31315 , Item No23 Diclofenac Ophthalmic Use Drop Cod. Article 26115 , Item No24 Dorzolamide Ophthalmic Use Drop Cod. Article 16757 , Item No25 Latanoprost Ophthalmic Use Drop Cod. Article 26256 , Item No26 Olopatadine Ophthalmic Use Drop Code. Article 26320 , Item No27 Ocular Hypotensor Association Cod. Article 26005 , Item No28 Tobramycine Ophthalmic Use Drop Code. Article 26427 , Item No29 Antibiotics And Associated Corticoids Ophthalmic Use Cod. Article 26092 , Item No30 Antibiotics And Associated Corticoids Ophthalmic Use Cod. Article 26092 , Item No. 31 Fluoresceine-Proparacaine Ophthalmic Solution Cod. Article 43255 , Item No32 Artificial Tears Ophthalmic Use Cod. Article 26253 , Item No33 Artificial Tears Ophthalmic Use Cod. Section 26253 |
Key Dates |
|
| Contract Date | 29 Apr 2026 |
Contact Information |
|||||||
View Notice Now...Login with your Social Account for Instant Access to this notice
|
|||||||